Search
forProducts matching "male androgenetic alopecia"
Tracking 12 products like 100 RU58841 Powder, 14 Topical Finasteride & Minoxidil Spray, 16 Oral Finasteride, 41 Minoxidil and 154 Duprost from by companies like MinoxidilMax, Hims, Roman and Inhouse Pharmacy. View all 12 products »Learn
5 / 10 resultslearn Dutasteride
Heavy duty finasteride that comes with higher risks, but scalp injections seem safe and are gaining popularity
learn Dexpanthenol
precursor of vitamin B5 with hair stimulating effects
learn Finasteride
Frontline, gold standard treatment for combatting androgenic alopecia
learn Minoxidil
An essential vasodilator with some anti-androgenic effects, has excellent safety record
Research
5 / 1000+ results![Male androgenetic alopecia](/images/research/e7c046e6-a880-4477-804c-9a4d12a78a81/small/2955.jpg)
research Male androgenetic alopecia
Hair loss in men treated best with early medication or transplant, new treatments researched.
![Male androgenetic alopecia](/images/research/49dcde38-fb13-4813-aa34-04e6c408317f/small/2417.jpg)
research Male androgenetic alopecia
DHT, a testosterone byproduct, causes male pattern baldness.
![Male androgenetic alopecia: Population-based study in 1,005 subjects](/images/research/8f8a89c9-a70c-4074-9a3b-8de2645596aa/small/2886.jpg)
research Male androgenetic alopecia: Population-based study in 1,005 subjects
58% of men aged 30-50 have hair loss, with severity increasing with age.
![Male androgenetic alopecia](/images/research/b9586722-5a96-451e-9d3d-ed5d5e1289b4/small/2571.jpg)
research Male androgenetic alopecia
Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.
![Male Androgenetic Alopecia and Cardiovascular Risk Factors: A Case-Control Study](/images/research/49fd3c03-5064-4f8a-a879-c551846e2608/small/2953.jpg)
research Male Androgenetic Alopecia and Cardiovascular Risk Factors: A Case-Control Study
Balding men have higher heart disease risk.
Community Join
5 / 1000+ resultscommunity Treatment of male androgenetic alopecia with topical products containing Serenoa repens (Saw Palmetto) extract.
The conversation discusses treating male pattern baldness with topical products containing Saw Palmetto extract. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.
community Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate
Comparing the effectiveness of minoxidil 5% and adenosine 0.75% for treating male androgenetic alopecia, and measuring patient satisfaction rate; results showed that adenosine is comparable to minoxidil but provides quicker results, however availability of products with adenosine is much less than those with minoxidil.
community Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia
Kintor Pharma completed enrolling subjects for a Phase III trial of KX-826 for male hair loss treatment. The trial includes a 24-week treatment period and a 4-week safety follow-up, with results expected in about 6-7 months.
community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.